红景天防治神经退行性疾病机制研究OA
Study on the Mechanism of Hongjingtian(Rhodiolae Crenulatae Radix Et Rhizoma)in Preventing and Treating Neurodegenerative Diseases
神经退行性疾病是神经元及髓鞘进行性退化、死亡导致神经功能丧失,进而出现运动障碍、认知障碍等症状的一类疾病,此类疾病发病机制错综复杂,目前尚未发现根治性治疗手段.中药防治神经退行性疾病具有天然温和、安全有效的独特优势.红景天为景天科红景天属植物的干燥根茎,是临床补气活血类中药的代表性药材,具有益气活血、通脉平喘的功效,现代药理学研究表明其具有抗氧化、抗炎、抗疲劳、神经保护、抗焦虑抑郁、调节免疫等多种作用.该文综合近10年国内外文献发现,红景天苷、酪醇、络塞维、槲皮素、熊果苷等红景天活性成分从抗氧化应激、抑制神经炎症、抑制神经凋亡、调节自噬活性、保护线粒体功能、促进神经发生、重塑肠道菌群、促进微血管再生与重构、抑制铁死亡、减少内质网应激、调控神经递质等方面多靶点、多通路、多途径发挥防治神经退行性疾病的作用.在临床应用中,含红景天的复方制剂在治疗阿尔茨海默病、帕金森病、癫痫、缺血性中风、多发性硬化等神经退行性疾病中显示出独特疗效.该文系统梳理了红景天的研究现状,以期为其在神经退行性疾病的基础研究和临床应用提供参考.
Neurodegenerative diseases are a group of disorders characterized by progressive degeneration and death of neurons and myelin sheaths,leading to neurological dysfunction and symptoms such as motor impairment and cognitive decline.The pathogenesis of these diseases is complex,and no definitive cure has been identified to date.Traditional Chinese medicine(TCM)offers unique advantages in preventing and treating neurodegenerative diseases due to its natural,mild,safe,and effective properties.Hongjingtian(Rhodiolae Crenulatae Radix Et Rhizoma),the dried rhizome of Rhodiola crenulata H.,is a representative herb in TCM's Qi-tonifying and blood-activating category.It is known for its effects in replenishing Qi,activating blood circulation,and relieving asthma.Modern pharmacological studies have demonstrated its multiple benefits,including antioxidant,anti-inflammatory,anti-fatigue,neuroprotective,anti-anxiety,and immune-regulating properties.This review synthesizes domestic and international literature from the past decade,revealing that active components of Hongjingtian(Rhodiolae Crenulatae Radix Et Rhizoma),such as rhodiola glycosides,tyrosol,rosavin,quercetin,and arbutin exert multifaceted effects through multiple targets,pathways,and mechanisms.These include combating oxidative stress,inhibiting neural inflammation,preventing neuronal apoptosis,regulating autophagy,protecting mitochondrial function,promoting neurogenesis,reshaping gut microbiota,facilitating microvascular regeneration,suppressing ferroptosis,reducing endoplasmic reticulum stress,and modulating neurotransmitters.Clinically,Hongjingtian(Rhodiolae Crenulatae Radix Et Rhizoma)-based formulations have shown remarkable efficacy in treating neurodegenerative diseases such as Alzheimer's disease,Parkinson's disease,epilepsy,ischemic stroke,and multiple sclerosis.This study systematically reviews the current research status of Hongjingtian(Rhodiolae Crenulatae Radix Et Rhizoma)to provide insights for its application in both basic research and clinical practice.
张仙茹;郑崇玲;张杰;苗琦;张令媛;苏雯;刘宗梅;曹旸
陕西中医药大学,陕西 咸阳 712046陕西中医药大学,陕西 咸阳 712046陕西中医药大学,陕西 咸阳 712046陕西中医药大学附属医院,陕西 咸阳 712000陕西中医药大学附属医院,陕西 咸阳 712000陕西中医药大学附属医院,陕西 咸阳 712000陕西中医药大学附属医院,陕西 咸阳 712000陕西中医药大学附属医院,陕西 咸阳 712000
医药卫生
红景天神经退行性疾病阿尔茨海默病帕金森病癫痫缺血性中风多发性硬化
Hongjingtian(Rhodiolae Crenulatae Radix Et Rhizoma)neurodegenerative diseasesAlzheimer's diseaseParkinson's diseaseepilepsyischemic strokemultiple sclerosis
《辽宁中医药大学学报》 2026 (9)
71-77,7
中国民族医药学会科研项目(2023ZY175-53)陕西省卫生健康委员会第四批省级学科带头人访学研修项目(陕卫办人函[2025]161号)陕西省第三届名中医杨志宏传承工作室建设项目(陕卫中医发2019004号)陕西中医药大学研究生质量提升工程专项项目(CXSJ202407)
评论